Computer Assisted Analysis of Insulin Response to Glucose Stimulus
|
|
- Maud Welch
- 5 years ago
- Views:
Transcription
1 A n n a l s o f C l in ic a l L a b o r a t o r y S c ie n c e, Vol. 3, N o. 6 Copyright 1973, Institute for Clinical Science Computer Assisted Analysis of Insulin Response to Glucose Stimulus CHARLES R. McREYNOLDS, M.D., SHARFUDDIN SHAH, M.D., AND ROBERT P. STOFFER, M.D. The Hertzler Research Foundation, The Hertzler Clinic, Halstead, KS ABSTRACT Concomitant measurements of plasma insulin levels were performed on all samples of blood obtained from 1,408 patients undergoing a diagnostic oral glucose tolerance test. These patients had no prior diagnosis of diabetes but qualified for the study because of either suspicious history, family history, or signs and symptoms. Graphic display of the findings, with insulin plotted as percent increase over basal level and glucose as milligrams per ml, resulted in recognizably distinct patterns of response in both nondiabetic and diabetic patients. Computer assisted analysis of these, along with correlation of the factor of obesity, confirmed the recognizably separate patterns. The concept of the initial lesion of insulin deficiency of diabetes as one of rate rather than magnitude tends to be confirmed. It was concluded that the routine and simultaneous performance of plasma insulin levels during oral glucose tolerance tests was of value in the diagnosis of various stages of diabetes and in selection of the proper treatment regime. Introd u ction The diagnosis of diabetes depends on the proper use and interpretation of clinical laboratory procedures that detect elevated blood glucose levels. Of the variety of tests available for this purpose, the oral glucose tolerance test (OGGT) is of singular value. 3 Since the advent of the radioimmunoassay (RIA) technique for measuring circulating insulin in I960,12 a wealth of new information has re-established the importance of insulin deficit as the primary but not the only underlying defect in diabetes. In view of the accepted value of these two laboratory tests, a survey was undertaken in a large series of patients to determine whether or not the routine performance of the tests might adduce information that could be used to facilitate the diagnosis and/or management of all types and stages of diabetes. M ethod and M aterial P a t ie n t P o p u l a t io n The participants in this prospective survey were derived from a large patientpopulation that, during the latter half of 1972, underwent diagnostic work-ups at a
2 COM PUTER ANALYSIS OF INSULIN RESPONSE large group-practice facility. Admission to the survey was on the basis of one or more of the following: ( 1 ) an increased fasting blood glucose; (b) an increased two-hour glucose test; (3) a family history of diabetes and (4) signs and symptoms indicative of diabetes. Patients with an established diagnosis of diabetes were excluded from the series. Of the 1,554 patients originally included in the survey, 146 of them subsequently had to be excluded as a result of missing demographic data and/or questionable laboratory results. The remaining group of 1,408 patients was comprised of 839 females and 569 males. The females ranged in age from 13 to 92 years (average age was 51.9), and the males from 12 to 85 years (average age was 49.6). Virtually all the patients were seen on an in-patient basis. L a b o r a t o r y P r o c e d u r e s Oral Glucose Tolerance Test ( OGTT). Standard OGTTs were performed on all in-patients and whenever possible on outpatients. Despite out-patients being instructed in a diet containing approximately 250 g of carbohydrates to be ingested for three days prior to the test day, rigid insistence on this was not always enforced, since it has been shown that a diet containing 150 g would not invalidate the test results. 3 All patients fasted for 12 hours prior to the start of the test. Venous blood, taken from the antecubital vein, was employed for all analyses. After a fasting specimen was drawn, g of a flavored glucose meal was given. Venous samples were subsequently drawn at 60, 90, 120, and 180 minutes in all patients, and at 240 and 300 minutes in selected patients (those suspect of reactive hypoglycemia). The data obtained from these latter two samples are not considered in this report. All samples were centrifuged within 30 minutes after being withdrawn, and glucose determinations were made the same day on plasma by the potassium ferricyanide (Auto-Analyser) method. Results of the OGTT were reported as mg of glucose per ml of plasma. Samples were collected in a seven ml vacutainer containing five mg of thymol and 50 mg of sodium fluoride. Plasma Insulin Levels. An aliquot of the plasma used for each glucose determination was either immediately assayed for insulin or frozen and assayed later (within 24 to 48 hours). A radioimmunoassay ( Phadebas Insulin Test) noted for its technical simplicity was utilized throughout the survey. In this test, specific antibodies to insulin are covalently coupled to a solid phase immunosorbent (cross-linked dextran), and the insulin in an unknown sample is allowed to compete with a fixed amount of Il25-insulin for the binding sites on the insulin antibodies. This competitive capacity is then compared with that of standard insulin preparations of known concentration. With this technique, the time-consuming steps required by the older double-antibody techniques is considerably shortened (minimum incubation time is three hours). Free and bound radiolabeled antigen are easily separated by conventional centrifugation. The results of this test were reported as micro-units of insulin per ml of plasma. The optimal conditions under which this assay should be performed have recently been described, as have its exceptional reproducibility, sensitivity and reliability. 10 Data Collection and Processing. Demographic and laboratory test results were recorded on forms suited to graphic analysis and conventional data-reduction techniques. Demographic data included body weight, height, age, sex and a series of questions relative to the history and treatment of diabetes. Graphic Analysis. Individual blood glucose and plasma insulin levels were plotted on the same graph as a simple means of classifying patients as either nondiabetic
3 C l a s s i f i c a t i o n o f P a t i e n t s A c c o r d i n g t o C o m p a r a t i v e S e c r e t o r y R e s p o n s e s Number of Sex Graphic Description of Glucose Patients Distribution Mean Age Mean Weight Obesity and Insulin Curves in Group (females/males) ± S E M * ± S E M Nonobese\ Nondiabetic ± ± ± ± Malabsorption type of curve ± ± ± ± Transient hypoglycermia with ± ± slightly elevated insulin ± ± Normal glucose tolerance with ± ± high insulin output ± ± Normal glucose tolerance with ± ± low insulin output ± ± Altered glucose tolerance with ± ± high insulin output ± ± Adult onset diabetes with ± ± high insulin output ± ± Moderately severe diabetes with ± ± low insulin output ± ± * Standard error of mean. f Nonobese = actual weight < 115 percent of adjusted ideal weight; obese = actual weight > 115 percent of adjusted ideal weight MCREYNOLDS, SHAH AND ST O FFER TABLE I
4 COM PUTER ANALYSIS OF INSULIN RESPONSE 'J9 3 n e I o o o» _ n M i n u t e s F i g u r e la. Mean glucose ( ) and plasma insulin ( O------O ) values in 408 nondiabetics. For SEM, see table I. ( normal ) or diabetic. A classification of diabetic was given to patients whose glucose was greater than 130 mg per 100 ml, or whose 60, 90, and 120 minute levels were over 185, 160, and 140 mg per ml. Patients were categorized as borderline when one or two of the OGTT values were abnormal. Glucose values were plotted linearly, i.e., as mg per ml, whereas insulin values were plotted as a percent change from the basal level. This latter technique, which has been reported to exclude effects due to obesity, 1 served to amplify the insulinogenic response to the glycemic stimulus and thereby facilitate the classification of patients into subgroups according to their comparative secretory responses (table I). Computer Assisted Analysis. The programming and computer (IBM ) facilities of a large university were employed to process the data that had been collected during the survey. Segments of the demographic data were utilized to calculate body surface area (DuBois For F i g u r e lb. Mean glucose values in obese ( ) and nonobese ( O O ) nondiabetics together with mean corresponding insulin values for same group. For SEM, see table II. mula) and ideal body weight. The ideal body weight obtained was then individually adjusted for age, height, and sex. 9 A classification of nondiabetes or diabetes and the type of diabetes was made by one of the authors (usually a practicing clinician) on the basis of adjusted Fajans-Conn Criteria. 4 All pertinent data was displayed for each individual within the group classifications listed in table I. Within each classification, individual data was broken down according to the sex of the patient and whether or not he was obese. Patients whose actual weight exceeded 115 percent of their adjusted ideal weight were considered obese. 6 Biostatistical routines were employed to calculate means, standard deviation of the mean and standard error of the mean ( SEM ), 2 Results On the combined evaluation of the blood glucose and plasma insulin levels they exhibited it was possible to classify the 1,408
5 4 5 8 MCREYNOLDS, SHAH AND ST O FFE R M in u te s F i g u r e 2a. Mean glucose ( ) and plasma insulin ( O O ) values in 96 patients with malabsorption syndrome. For SEM, see table I. M in u te s F i g u r e 2b. Mean glucose and plasma insulin values for two groups of patients with normal GTT values and high (O------O) and low (A A ) output of insulin. For SEM, see table I. participants in the survey into eight fairly distinct groups (table I). Five of the eight groups enumerated in this table are comprised of 574 ( 369 females and 205 males) nondiabetics. The three remaining groups, which total 834 patients (470 females and 364 males) are comprised of borderline diabetics (243 patients), adult onset diabetics (433 patients) and moderately severe diabetics with low insulin output (158 patients). Comparisons of the mean glucose and insulin levels for males and females failed to show any significant differences, regardless of whether or not the individuals comprising the group were diabetic or nondiabetic. Since the comparisons confirmed the fact that glucose tolerance and insulin concentration during glucose tolerance tests are independent of sex, 5 no further attempt will be made to distinguish possible differences due to this factor. Considerable attention will be directed toward discovering differences between obese and nonobese diabetics, since it has been shown that obesity and not carbohydrate intolerance is associated with elevated fasting insulin levels. 1 N o n d ia b e t ic P a t ie n t s Although 574 of the participants in this survey were classified as being nondiabetics, only 405 of them qualified as such on the basis of having glucose values throughout the entire OGTT within normal limits and having plasma insulin values that reflected a proportional and parallel response to the corresponding stimulus (figure la ). On the whole, the mean glucose values for the 87 (21.5 percent) obese patients in this group were insignificantly higher than corresponding values for the nonobese patients (figure lb ). While the mean fasting
6 CO M PU TER ANALYSIS O F INSULIN RESPONSE insulin levels in both groups are only slightly different, considerably higher mean levels occur at 60 and 90 minutes. These differences are statistically significant (p 0.05) whereas the differences at 120 and 180 minutes are not. It is doubtful that such transient differences have any clinical significance. More important, perhaps, is the fact that the shapes of the insulin curves in this figure are entirely parallel, and devoid of any delay in the insulinogenic response to the glycemic stimulus. Of the remaining 169 patients classified as nondiabetic, 96 of them presented glucose tolerance curves indicative of malabsorption syndrome. The absence of any significant glycemic stimulus in this group of patients is accurately reflected in the mean immunoreactive insulin test-values presented in figure 2a. The remainder of the nondiabetic groups are, by comparison, quite small in number. Except for displaying the average mean glucose and insulin curves for the two larger groups (figure 2 b), no further attention will be accorded these patients. As for the data presented in figure 2 b, suffice it to say that, despite normal glucose tolerance curves, it was possible to show that the input of insulin was fairly high in one group (34 patients) and fairly low in the other group (31 patients). D ia b e t ic P a t ie n t s The mean glucose and insulin values for the three groups of patients classified as diabetic are presented graphically in figures 3a, b and c. Upon comparing the three glucose tolerance curves in this figure, two distinct trends are even more dramatic when the glucose curves are compared with the one depicted in figure la. The corresponding insulin curves reflect a somewhat similar trend on the one hand (figures 3a and b ), and a completely different picture on the other (figure 3 c). The shift upward and to the right in the insulin curves suggests a progressive worsening in the degree of diabetes exhibited by these patients. The insulin curve in figure 3a can be interpreted as lacking any major sign of V e e-i 3 3 ~ F i g u r e 3a F i g u r e 3a. Mean glucose ( ) and insulin (O O ) values in 243 borderline diabetics. For SEM, see table I. F i g u r e 3b F i g u r e 3b. Mean glucose ( ) and insulin (O O) values in 433 adult onset diabetics. For SEM, see table I. F i g 3c F i g u r e 3c. Mean glucose ( ) and insulin (O O) values in 158 moderately severe diabetics with low insulin output. For SEM, see table I.
7 4 6 0 MCHEYNOLDS, SHAH AND ST O FFER O 0Q(- \ C t- o o o «re c l - l O 70 h-' \ C > O O «O It 3 C M M in u tes F ig u re 4a Figure 4a. Mean glucose values in obese (A A ) and nonobese ( ) adult onset diabetics (figure 3b) together with corresponding mean plasma insulin values. For SEM, see table II. F ig u r e 4b F igure 4b. Mean glucose values in obese (A A ) and nonobese ( ) moderately severe diabetics (figure 3c) together with corresponding mean plasma insulin values. For SEM, see table II. pancreatic decom pensation. T here is, how ever, some delay in the release of insulin to the glycemic stimulus. A m uch longer delay in the pancreatic response to circulating glucose is evident from the insulin curve presented in figure 3b. Of equal im portance is the fact th a t the insulin values in this figure are fa r less proportional to th e corresponding glucose values than are the ones in figure 3a. This lack of proportionality has been interpreted by others to signify a decreasing insulin response to glucose.1 6 The curves presented in figure 3c need little if any amplification. T he m ean fasting blood sugar is only slightly elevated, whereas the glycemia following the glucose load is fairly exaggerated throughout the rem aining intervals of the GTT. The m ean fasting insulin level is higher in this group of patients th an in any other, and the virtual absence of any insulinogenic response to high circulating levels of glucose is striking. O b e s it y In contrast to the accepted belief th at most diabetics (or at least most adult-onset diabetics1) are obese, it should be noted th a t the overall incidence of obesity in the 1,408 patients included in this survey was only 27.3 percent. T he incidence of obesity in 834 patients classified as having some form of diabetes was only slightly higher, i.e., 31.2 percent. T he selection of patients m ay account for this discrepancy, as known or previously diagnosed diabetics tended to b e excluded from this study. T he effect of obesity on the glucose tolerance and serum insulin values of obese and nonobese nondiabetic and diabetics is
8 C O M P U T E R A N A LYSIS O F IN SU L IN R ESPO N SE summarized in table II and in figures 4a and b. By inspection of the mean curves presented in these figures, the fasting plasma insulin in the obese adult-onset diabetics is neither elevated nor significantly different from the fasting value in their nonobese counterparts. This finding is in agreement with that of others6 7 8 but disagrees with the findings of at least two other groups of workers. 1 5 The hyperinsulinemia at all times subsequent to the fasting value is an expected finding in obese and nonobese adult onset diabetics. C om m en t The findings of the present survey have at least two interpretations. One is that they lend additional support to several concepts held by leading diabetologists. The other, and perhaps the more important of the two, is that they leave little doubt that the routine determination of plasma insulin levels with all OGTTs does indeed adduce information that has considerable value in the diagnosis and management of diabetes. The details surrounding these two interpretations are given. The overall findings of the survey and, more specifically, the mean glucose and insulin levels depicted in figures 3a, b, and c, lend support to the fairly widely held concept that the natural history of diabetes involves a series of stages, starting with prediabetes or potential diabetes and continuing through latent diabetes to manifest diabetes. It should be emphasized, however, that the lines of demarcation between these stages are rarely clear-cut. Instead, there is a good deal of overlap between them which can make diagnosis a most difficult task. This is particularly true in the face of concomitant obesity. As can be seen from the distribution of the population in this survey in each of the three categories of diabetes (tables I and II), far fewer patients are in the stage of manifest diabetes than are in the stage of borderline diabetes or mild onset maturity diabetes. The basis for the transition from one stage to another is as yet, unclear. The present findings also support the concept that diabetes mellitus is fundamentally a disease in which the underlying cause is a deficient secretion of insulin. In the initial stages of the disease, the deficiency is not necessarily absolute but, as has been suggested, 6 a deficiency in the rate of insulin secretion. Sooner or later, however, insulin output is obtunded and the deficiency becomes absolute. Evidence for this from the present survey can be found by comparing the mean insulin curves presented in figures 3a, b and c. The first of these three curves reflects what has been called a biochemical inertia in that the release of insulin in response to hyperglycemia is excessive as well as delayed. In the second of the three figures, an even greater glycemic stimulus is required to overcome the inertia of the most severely decompensated beta cell. The prolonged postprandial hyperglycemia is, of course, the pathophysiologic condition of major concern. Finally, the last of the three curves reflects a reduced insulin secretory reserve, which is generally taken to represent the step in the natural history of diabetes that preceded unrelenting, aroundthe-clock hyperglycemia. Since the regulation of glycemia resides primarily in the release of insulin by the pancreas, and since it is both the speed and degree of the release that are usually impaired in diabetics, the routine performance of plasma insulin levels in such patients should really need no recommendation. The present understanding of diabetes, while far from complete, has progressed to the point where the disorder can no longer be defined in terms of high blood glucose. Instead, it must be defined on the basis of whether or not the high blood glucose exists in the presence of an adequate insulin response and poor insulin
9 Plasma Insulin n U nits / ml Nondiabetics (n = 405) Nonobese (n = 318) Mean ± S E M Obese (n = 87) Mean ' 60' n Fr-34 ± S E M Nonobese (n = 101) Mean !) ± S E M Obese (n = 57) Mean ± S E M Oi to MCREYNOLDS, SHAH AND ST O FFE R T A B L E II E f f e c t j d f O b e s i t y o n G l u c o s e T o l e r a n c e a n d S e r u m I n s u l i n V a l u e s o f O b e s e a n d N o n o b e s e N o n d i a b e t i c s a n d D i a b e t i c s Fasting Glucose Tolerance (mg/100 ml) Fasting Adult-onset diabetics (n = 433) Nonobese (n = 313) Mean ± S E M Obese (n = 120) Mean ± S E M C Moderately severe diabetics (n = 158)
10 C O M PU TES ANALYSIS OF INSULIN BESPON SE utilization, i.e., insulin resistance, as in the case of grossly obese patients, or whether or not it exists in the presence of a delayed insulin release (figure 3b), or in the absence of a significant release of insulin (figure 3c). Unfortunately, the cause of the development of insulin resistance in obese patients is still not known. Patients of this type, as well as those in whom the release of insulin is delayed, rarely require the administration of insulin. Instead, a reducing diet and, if necessary, the temporary administration of an oral hypoglycemic agent often result in satisfactory regulation. In the absence of any significant insulinogenic response to hyperglycemia, treatment with insulin may be the only effective form of treatment. Sum m ary A prospective survey is described in which the objective was to determine whether or not the routine radioimmunoassay of plasma insulin levels during standard oral glucose tolerance tests (OGTTs) might adduce information that could be used to facilitate the diagnosis and/or management of all types and stages of diabetes. Glucose determinations were made on plasma by the potassium ferricyanide (Auto-Analyser) method. A radioimmunoassay noted for its reproducibility and technical simplicity (Phadebas Insulin Test) was employed for measuring plasma insulin levels. Glucose was reported in mg per ml and insulin in micro-units per ml. Data analysis was computer-assisted. The findings of this survey lend support to the concept that the natural history of diabetes involves a series of stages, and that the lines of demarcation between them are not clear-cut, especially when clinical findings include obesity. Obesity was not, however, as frequent a complication in the diabetic patient-population studied as it is usually reported in the literature. The findings relative to plasma insulin levels also lend support to the concept that, at least initially, the insulin deficiency of diabetes is one of rate rather than magnitude. As measured by the radioimmunoassay employed in this large series, insulin levels in the later stages of diabetes indicate not only a deficiency in the rate of secretion, but also a deficiency in the amount of hormone being secreted. Overall, the information gained from the simultaneous and routine performance of a standard OGTT and immunoreactive plasma insulin test in this survey of 1,408 patients aided in the diagnosis of various types of diabetes. Having knowledge of each patient s insulin response to the glycemic stimulus also provided an important basis for selecting an individualized treatment regimen. Acknowledgment The authors would like to thank Richard Mautner for his valuable assistance with the programming and data processing aspects of the survey. References 1. B a g d a d e, J. D., B i e r m a n, E. L., a n d P o r t e, D., Jr.: The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. Clin. Invest. 46: , BMD: Biomedical Computer Programs, Dixon, W. J., ed. Health Sciences Computing Facility. University of California, Los Angeles, F a j a n s, S. S.: What is diabetes? Definition, diagnosis, and course. Symposium on diabetes mellitus. Med. Clin. No. Amer. 55: , F a j a n s, S. S. a n d C o n n, J. W.: Prediabetes, subclinical diabetes and latent clinical diabetes: Interpretation, diagnosis and treatment. On the Nature and Treatment of Diabetes. Excerpta Med. Int. Congress Series No. 84, New York, pp , J o r g e n s e n, K. R.: Radioimmunoassay of insulin in plasma and urine in obese subjects and diabetic patients. Acta Endocrinol. 60: , S e l t z e r, H. S., A l l e n, E. W., H e r r o n, A. L., J r., a n d B r e n n a n, M. T.: Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J. Clin. Invest. 46: , S e l t z e r, H. S. a n d H a r r i s, V. L.: Exhaustion of insulogenic reserve in maturity-onset diabetic patients during prolonged and contin
11 4 6 4 M C REYN O LD S, SH AH AND S T O F F E S uous hyperglycemic stress. Diabetes 13:6-13, S e l t z e r, H. S. a n d S m i t h, W. L.: Plasma insulin activity after glucose. An index of insulinogenic reserve in normal and diabetic man. Diabetes 8: , Statistical Bulletin 40, Metropolitan Life Insurance Company, V e l a s c o, C. A., O p p e r m a n n, W., a n d C a m - e b i n i - D a v a l o s, R. A.: Critical variables in the radioimmunological technique for measuring immunoreactive insulin with use of immunosorbents. Clin. Chem. 19: , W i l k e r s o n, H. L. C.: Diagnosis, oral glucose tolerance tests. Diabetes Mellitus, Diagnosis and Treatment. American Diabetes Association, New York, pp , Y a l o w, R. S. a n d B e r s o n, S. A.: Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 39: , Rule 1. The Chief is right. THE C H IEFS BASIC RULES Rule 2. In the impossible hypothesis that a subordinate may be right, rule 1 becomes immediately operative. Rule 3. The Chief does not sleep: he rests. Rule 4. The Chief is never late: he is delayed elsewhere. Rule 5. The Chief never leaves his work: his presence is required elsewhere. Rule 6. The Chief never reads the paper in his office: he studies. Rule 7. The Chief never takes liberties with his secretary: he educates her. Rule 8. Whoever may enter the Chiefs office with an idea of his own must leave the office with his Chiefs ideas. Rule 9. The Chief is always Chief even in bathing togs. Lancet 2:36, July 7, 1973
Insulin release, insulin sensitivity, and glucose intolerance (early diabetes/pathogenesis)
Proc. Natl. Acad. Sci. USA Vol. 77, No. 12, pp. 7425-7429, December 1980 Medical Sciences nsulin release, insulin sensitivity, and glucose intolerance (early diabetes/pathogenesis) SUAD EFENDt, ALEXANDRE
More informationNormalization of Growth Hormone
Downloaded from http://www.jci.org on November 24, 217. https://doi.org/1.1172/jci16671 Normalization of Growth Hormone Hyperresponse to Exercise in Juvenile Diabetics after "Normalization" of Blood Sugar
More informationAcute and Steady-State Insulin Responses
Acute and Steady-State nsulin Responses to Glucose in Nonobese Diabetic Subjects ROGER L. LERNER and DANEL PORTE, JR. From the University of Washington School of Medicine and Veterans Administration Hospital,
More informationEFFECT OF VAGOTOMY AND PYLOROPLASTY: THE ORAL GLUCOSE TOLERANCE TEST
GASTROENTEROLOGY 64: 217-222, 1973 Copyright 1973 by The Williams & Wilkins Co. Vol. 64, No.2 Printed in U.S.A. EFFECT OF VAGOTOMY AND PYLOROPLASTY: THE ORAL GLUCOSE TOLERANCE TEST W, H, HALL, M,D" L.
More informationWhen, however, the adreno-cortical extract was given before the test a
CORTISONE INDUCED IMPAIRMENT OF GLUCOSE TOLERANCE IN THE DETECTION OF THE DIABETIC DIATHESIS. BY L. J. P. DUNCAN. From the Department of Therapeutics, University of Edinburgh. (Received for publication
More informationA Comparison of Leucine- and Acetoacetate-induced Hypoglycemia in Man *
Journal of Clinical Investigation Vol. 43, No. 1, 1964 A Comparison of Leucine- and Acetoacetate-induced Hypoglycemia in Man * STEFAN S. FAJANS, JOHN C. FLOYD, JR., RALPH F. KNOPF, AND JEROME W. CONN (From
More informationBlood Sugar Screening Levels*
April, 1951 A Preliminary Report on a Study of Blood Sugar Screening Levels HUGH L. C. WILKERSON, M.D., F.A.P.H.A., AND BARBARA GLENN Chief; and Statistician, Diabetes Branch, Division of Chronic Diseases,
More informationRelation of Delayed Initial Release to Carbohydrate Intolerance in Mild Diabetes Mellitus *
Journal of Clinical Investigation Vol. 46, No. 3, 1967 Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate Intolerance in Mild Diabetes Mellitus * HOLBROOKE
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationFact Sheet #55 November Program on Breast Cancer. and Environmental Risk Factors (BCERF)
Program on Breast Cancer Environmental Risk Factors Fact Sheet #55 November 2006 TOPICS Carbohydrates in our diet Carbohydrates and breast cancer risk Carbohydrates and glycemic index Glycemic index and
More informationDetection of Diabetes Mellitus In Situ (Occult Diabetes)
Detection of Diabetes Mellitus In Situ (Occult Diabetes) by Joseph R. Kraft, M.D. In recent years, further development and refinement of technique has permitted reproducible serum insulin determinations
More informationStudy of significance of glycosylated hemoglobin in diabetic patient
Original Research Article Study of significance of glycosylated hemoglobin in diabetic patient Dimpal Modi 1*, Gunvanti B. Rathod 2, K. N. Delwadia 3, H. M. Goswami 4 1 Tutor, Pathology Department, GMERS
More informationComparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary
Number 14 Effective Health Care Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes Executive Summary Background and Key Questions
More informationAlternative insulin delivery systems: how demanding should the patient be?
Diabetologia (1997) 4: S97 S11 Springer-Verlag 1997 Alternative insulin delivery systems: how demanding should the patient be? K.S. Polonsky, M. M. Byrne, J. Sturis Department of Medicine, The University
More informationCURVE OF SUGAR EXCRETION IN SEVERE DIABETES.
CURVE OF SUGAR EXCRETION IN SEVERE DIABETES. BY HANNAH FELSHER. (From the Otho S. A. Sprague Memorial Institute Laboratory oj Clinical Research, Rush Medical College, Chicago.) (Received for publication,
More information28 Regulation of Fasting and Post-
28 Regulation of Fasting and Post- Prandial Glucose Metabolism Keywords: Type 2 Diabetes, endogenous glucose production, splanchnic glucose uptake, gluconeo-genesis, glycogenolysis, glucose effectiveness.
More informationINSULIN RESPONSE IN GLUCOSE-TOLERANCE TESTS
THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY Copyright 1967 by The Williams & Wilkins Co. Vol. 47, No. 0 Printed in U.S.A. INSULIN RESPONSE IN GLUCOSE-TOLERANCE TESTS STANLEY BURROWS, M.D. Department of
More informationChapter 14 Elderly, Home and Long-term Care Collections. Objectives:
EXERCISE 11: BEDSIDE GLUCOSE TESTING Textbook: Skills: Chapter 14 Elderly, Home and Long-term Care Collections 15 points Objectives: 1. Define diabetes mellitus. 2. Compare and contrast: Type 1 Diabetes,
More informationImpaired glucose tolerance and growth hormone in chronic liver disease
Gut, 1981, 22, 3135 Impaired glucose tolerance and growth hormone in chronic liver disease W J RILY* AND V J McCANN From the Department of Biochemistry and Diabetic Unit, Royal Perth Hospital, Perth, Western
More informationInsulin Secretion in Diabetes Mellitus
A Role for AlphaAdrenergic Receptors in Abnormal nsulin Secretion in Diabetes Mellitus R. PAUL ROBERTSON, JEFFREY B. HALTER, and DANiEL PORTE, JR. From the University of Washington School of Medicine and
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationdiabetes mellitus and chronic pancreatitis
Gut, 1966, 7, 277 Exocrine and endocrine pancreatic function in diabetes mellitus and chronic pancreatitis N. PETERS1, A. P. DCK, C. N. HALES, D. H. ORRELL, AND MARTN SARNER1 From Addenbrooke's Hospital
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More informationReport Reference Guide. THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1
Report Reference Guide THERAPY MANAGEMENT SOFTWARE FOR DIABETES CareLink Report Reference Guide 1 How to use this guide Each type of CareLink report and its components are described in the following sections.
More informationAwareness About Diabetes in Diabetic Patients and General Population
Awareness About Diabetes in Diabetic Patients and General Population Tanweer Alam 1,2, Saima Asif 1, Safila Naveed 1 and Khan Usmanghani 1 1 Faculty of Pharmacy, Jinnah University for Women 2 Drug Regulatory
More informationDKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014
DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol Glycemic Task Force September 2014 Hyperglycemic Crises: Pathophysiology DKA HHS Hyperglycemia DKA HHS Umpierrez, In Shoemaker,
More informationThe oral meal or oral glucose tolerance test. Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Original Article Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol Minimal Model Assessment of -Cell Responsivity and Insulin Sensitivity in Nondiabetic Individuals Chiara Dalla Man,
More information1. PATHOPHYSIOLOGY OF DIABETES MELLITUS
1. PATHOPHYSIOLOGY OF DIABETES MELLITUS Prof. Vladimir Palicka, M.D., Ph.D. Institute for Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic Diabetes mellitus is
More informationAGENDA for 10/31/13 AGENDA: HOMEWORK: Due end of period. Due Fri, OBJECTIVES:
AGENDA for 10/31/13 AGENDA: 1. 2.1.1: Diagnosing Diabetes Part 2 Glucose Tolerance Testing Part 3 Insulin Level Testing OBJECTIVES: 1. Make an initial diagnosis of diabetes and characterize the disease
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationo^ &&cvi AL Perceptual and Motor Skills, 1965, 20, Southern Universities Press 1965
Ml 3 Hi o^ &&cvi AL 44755 Perceptual and Motor Skills, 1965, 20, 311-316. Southern Universities Press 1965 m CONFIDENCE RATINGS AND LEVEL OF PERFORMANCE ON A JUDGMENTAL TASK 1 RAYMOND S. NICKERSON AND
More informationThe Role of Certified Diabetes Educators Helping to Smooth the Transition to Insulin: Overcoming Psychological Insulin Resistance
The Role of Certified Diabetes Educators Helping to Smooth the Transition to Insulin: Overcoming Psychological Insulin Resistance Beverly S. Adler, PhD, CDE Clinical Psychologist Certified Diabetes Educator
More informationGestational Diabetes. Gestational Diabetes:
Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,
More informationCausal Modeling of the Glucose-Insulin System in Type-I Diabetic Patients J. Fernandez, N. Aguilar, R. Fernandez de Canete, J. C.
Causal Modeling of the Glucose-Insulin System in Type-I Diabetic Patients J. Fernandez, N. Aguilar, R. Fernandez de Canete, J. C. Ramos-Diaz Abstract In this paper, a simulation model of the glucoseinsulin
More informationnorepinephrinee." 2 PNMT activity is stimulated by certain adrenocortical markedly,3' 4 but can be restored to normal by the administration of
IMPAIRED SECRETION OF EPINEPHRINE IN RESPONSE TO INSULIN AMONG HYPOPHYSECTOMIZED DOGS* BY RICHARD J. WURTMAN, ALFRED CASPER, LARISSA A. POHORECKY, AND FREDERIC C. BARTTER DEPARTMENT OF NUTRITION AND FOOD
More informationESPEN Congress Madrid 2018
ESPEN Congress Madrid 2018 Dysglycaemia In Acute Patients With Nutritional Therapy Mechanisms And Consequences Of Dysglycaemia In Patients Receiving Nutritional Therapy M. León- Sanz (ES) Mechanisms and
More informationThe endocrine system is complex and sometimes poorly understood.
1 CE Credit Testing the Endocrine System for Adrenal Disorders and Diabetes Mellitus: It Is All About Signaling Hormones! David Liss, BA, RVT, VTS (ECC) Platt College Alhambra, California For more information,
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationBlood Glucose Metabolism Instructor s Guide
Blood Glucose Metabolism Instructor s Guide Time to Complete Recommended time to complete 45-60 minutes Prior Knowledge Students should have a basic understanding of the function of glucose in normal metabolism.
More informationDiabetologia 9 Springer-Verlag 1982
Diabetologia (1982) 22:245-249 Diabetologia 9 Springer-Verlag 1982 Twenty-Four Hour Profiles of Plasma C-Peptide in Type 1 (Insulin-Dependent) Diabetic Children G. A. Werther 1 *, R. C. Turner 2, P. A.
More informationPancreatic Insulinoma Presenting. with Episodes of Hypoinsulinemic. Hypoglycemia in Elderly ---- A Case Report
2008 19 432-436 Pancreatic Insulinoma Presenting with Episodes of Hypoinsulinemic Hypoglycemia in Elderly ---- A Case Report Chieh-Hsiang Lu 1, Shih-Che Hua 1, and Chung-Jung Wu 2,3 1 Division of Endocrinology
More informationSafety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus Journal Club (May 2013) Sara Al-Sharhan, Pharm D intern-
More informationDiabetes mellitus - diagnosis, classification and acute complications. David Karásek 3rd Department of Internal Medicine University Hospital Olomouc
Diabetes mellitus - diagnosis, classification and acute complications David Karásek 3rd Department of Internal Medicine University Hospital Olomouc Diabetes mellitus is a group of metabolic diseases, characterized
More informationCARBOHYDRATE METABOLISM Disorders
CARBOHYDRATE METABOLISM Disorders molecular formula C12H22O11 Major index which describes metabolism of carbohydrates, is a sugar level in blood. In healthy people it is 4,4-6,6 mmol/l (70-110 mg/dl)
More informationDiabetes Mellitus Case Study
COLORADO STATE UNIVERSITY Diabetes Mellitus Case Study Medical Nutrition Therapy By: Emily Lancaster 9/28/2012 [Type the abstract of the document here. The abstract is typically a short summary of the
More informationOral Glucose Tolerance Test
J. med. Genet. (I965). 2, 221. Genetic Factors in Diabetes Mellitus Studied by the Oral Glucose Tolerance Test G. S. THOMPSON From the Nuffield Unit of Medical Genetics, Department of Medicine, University
More informationGROWTH HORMONE AND AMINO ACIDS
GROWTH HORMONE AND AMINO ACIDS Certain amino acids when combined with one another and ingested will cause an increase in growth hormone levels in humans. The increase in the body's production of growth
More information(7). Not all patients with these clinical syndromes respond to leucine, and the phrase "leucine-sensitive"
Journal of Clinical Investigation Vol. 41, No. 3, 1962 THE USE OF INSULIN IN THE PRODUCTION OF L-LEUCINE- INDUCED HYPOGLYCEMIA IN NORMAL DOGS * By G. REAVEN AND C. LUCAS f (From the Department of Internal
More informationFasting Plasma Glucose Reference Values among Young Japanese Women Requiring 75g Oral Glucose Tolerance Tests
Tokai J Exp Clin Med., Vol. 34, No. 1, pp. 15-2, 29 Fasting Plasma Glucose Reference Values among Young Japanese Women Requiring 75g Oral Glucose Tolerance Tests Yoko KOIKE *1, Yoichi OGUSHI *2, Dacheng
More informationEffect of eating frequency on prediabetes status: a self-controlled preventive trial
International Journal of Clinical Trials Dixit JV et al. Int J Clin Trials. 2017 Nov;4(4):171-175 http://www.ijclinicaltrials.com pissn 2349-3240 eissn 2349-3259 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3259.ijct20174118
More informationance of the sugar, until at plasma levels of 140 mgm. per cent the creatinine/sugar clearance ratio
THE RENAL EXCRETION OF CREATININE IN MAN BY JAMES A. SHANNON 1 (From The Department of Physiology, New York University College of Medicine, New York City) In a previous paper the evidence on the excretion
More informationGlucoregulation 1 of 27 Boardworks Ltd 2012
Glucoregulation 1 of 27 Boardworks Ltd 2012 2 of 27 Boardworks Ltd 2012 Glucose 3 of 27 Boardworks Ltd 2012 Glucose is a type of sugar. It is the basic fuel for aerobic respiration, which provides the
More informationRELATIONS BETWEEN INSULIN AND PITUITARY HORMONES IN AMINO ACID METABOLISM
RELATIONS BETWEEN INSULIN AND PITUITARY HORMONES IN AMINO ACID METABOLISM BY WILLIAM D. LOTSPEICH* WITH THE TECHNICAL ASSISTANCE OF JOAN B. SHELTON (From the Department of Physiology, Syracuse University
More informationMaximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE
Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese
More informationIMPACT OF RECENT CHANGES IN DIAGNOSTIC CRITERIA ON THE APPARENT NATURAL HISTORY OF DIABETES MELLITUS
AMERICAN JOURNAL OF EPIDIMIOLOCY Copyright 1983 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 117, No. 6 Fruited in U.SA. IMPACT OF RECENT CHANGES IN DIAGNOSTIC
More informationReport Reference Guide
Report Reference Guide How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used to generate the sample reports was from sample patient
More informationEstimation of Blood Glucose level. Friday, March 7, 14
Estimation of Blood Glucose level Importance Diagnosis and treatment of carbohydrate metabolism disorders Monitor the effectivity and response to an ongoing treatment procedure Control mechanism Insulin
More informationCME/CE QUIZ CME/CE QUESTIONS
CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation The University of Cincinnati College of Medicine designates this educational activity for a maximum of two (2) AMA PRA Category 1
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationCareLink. software REPORT REFERENCE GUIDE. Management Software for Diabetes
CareLink Management Software for Diabetes software REPORT REFERENCE GUIDE How to use this guide Each type of CareLink report and its components are described in the following sections. Report data used
More informationPolycystic Ovary Syndrome
What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular
More informationMarch 2010, Issue 17. What's New at AMVS. In This Issue. 1 of 6 5/20/ :21 PM. 5 Practice Points for your Next Case. Dear Custom Field 1 Info,
1 of 6 5/20/2010 12:21 PM Having Trouble Viewing this Email? Click Here You're receiving this email because of your relationship with Aspen Meadow Veterinary Specialists. Please confirm your continued
More informationMETABOLIC EFFECTS OF SULFONYLUREAS IN NORMAL MEN AND IN VARIOUS TYPES OF DIABETIC PATIENTS*
METABOLC EFFECTS OF SULFONYLUREAS N NORMAL MEN AND N VAROUS TYPES OF DABETC PATENTS* By Stefan S. Fajans, Lawrence H. Louis, Allen R. Hennest, Bernard0 L. Wajchenbergt, Robert D. Johnson, Robert D. Gittler,
More informationUniphasic Insulin Responses to Secretin Stimulation in Man
Uniphasic Insulin Responses to Stimulation in Man ROGER L. LERNER and DANIEL PORTE, JR. From the University of Washington School of Medicine and Veterans Administration Hospital, Seattle, Washington 98108
More informationIntact Proinsulin DOZD\V \RXU SDUWQHU. Biomarker for insulin resistance associated with ȕ-cell dysfunction. Clinical Bulletin
Intact Proinsulin Biomarker for insulin resistance associated with ȕ-cell dysfunction Q Biomarker for ß-cell dysfunction in patients with Type 2 Diabetes mellitus Q Important secretion marker for the different
More informationEffect of Cobalt Chloride on Blood Glucose, Plasma Insulin and Lipids in Rabbits.
Effect of Cobalt Chloride on Blood Glucose, Plasma Insulin and Lipids in Rabbits. Masayoshi Ohmichi, Hiroyuki Morita, Yoko Onuma and Shigeo Koike Department of Hygiene, School of Medicine, Showa University,
More informationAmerican Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates
American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates Juan Pablo Frias, MD President and CEO, National Research Institute, Los Angeles, CA Clinical Faculty, University
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationGlucose Concentration Simulation for Closed-Loop Treatment in Type 1 Diabetes
American Society for Engineering Education (ASEE), Northeast Section Annual Conference, April 27-28, 208 Glucose Concentration Simulation for Closed-Loop Treatment in Type Diabetes Marilyn Urrea, Nora
More information4/23/2015. Linda Steinkrauss, MSN, PNP. No conflicts of interest
Linda Steinkrauss, MSN, PNP No conflicts of interest 1 5 year old African-American female presented to our Endocrinology Clinic with hypoglycemia Abnormal chromosomes Duplication of 11q13.5-11p14.1 affecting
More informationElevated Serum Human Growth Hormone and
Elevated Serum Human Growth Hormone and Decreased Serum Insulin in Prediabetic Males after Intravenous Tolbutamide and Glucose G. BODEN, J. S. SOELDNER, R. E. GLEASON, and A. MARBLE From the Elliott P.
More informationGlycated Hemoglobin/Glycated Protein
190.21 - Glycated Hemoglobin/Glycated Protein The management of diabetes mellitus requires regular determinations of blood glucose levels. Glycated hemoglobin/protein levels are used to assess long-term
More informationWhen and how to start insulin therapy in type 2 diabetes
When and how to start insulin therapy in type 2 diabetes Anne Kilvert MD, FRCP Most patients with type 2 diabetes will eventually require insulin due to the progressive decline in betacell function. Dr
More informationCarolyn Pheteplace. Department of Obstetrics and Gynecology,
Department of Obstetrics and Gynecology, Harvard Medical School, and Department of Surgery, Peter Bent Brigham Hospital. Boston, Massachusetts, U. S. A. FOLLICLESTIMULATING HORMONE AND LUTEINIZING HORMONE
More informationUnderstanding Glucose and Insulin Patterns With Dr. Ritamarie Loscalzo
Understanding Glucose and Insulin Patterns With Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one-onone relationship with a qualified health
More informationComplete Comprehensive Diabetes Educator modules available at CCCEP File #: I-P (Expires: Mar.
CDE Preparation Program Topics (Accredited by CCCEP for 0.5 CEUs/Module section Total = 20 CEUs) Module 1 Pathophysiology of Diabetes 5 segments Module 2 Diabetes and Nutrition 5 segments Module 3 Medications
More informationType 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM
Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes
More informationPhysiological Simulations: Plasma Glucose Regulation 1 Physiology Biology 390
Physiological Simulations: Plasma Glucose Regulation 1 Physiology Biology 390 I. An Introduction to this Lab and to Models 2 in General: The purpose of this exercise is to use a computer simulation to
More informationTest and graph the glucose levels in blood plasma samples collected during the patient s glucose tolerance test.
Diagnosing Diabetes: The Case: Your patient reports problems with fatigue and increased urination. You suspect that she might have diabetes. The results of her blood tests indicate that her blood glucose
More informationName: Oasis: Questions EPCP. Professional Development: Diabetes
EPCP Professional Development: Diabetes Name: Oasis: Questions 1) Type 1 diabetes in characterized by which of the following: 1) adult onset, obesity 2) juvenile onset, lean build 3) auto-immune beta cell
More informationBasal Bolus Insulin Therapy Frequently Asked Questions
1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong
More informationsuggested that this improvement is directly associated
CHANGES IN THE GLUCOSE TOLERANCE OF OBESE SUBJECTS AFTER WEIGHT REDUCTION By ROGER S. HUBBARD AND EDGAR C. BECK (From the Buffalo General Hospital and the University of Buffalo Medical School, Buffalo)
More informationThe absorption of water from the whole stomach. or one of its parts has not been demonstrated. Many years ago Pavlov showed that water was a
GASTRIC SECRETION. III. THE ABSORPTION OF HEAVY WATER FROM POUCHES OF THE BODY AND ANTRUM OF THE STOMACH OF THE DOG By OLIVER COPE, HESTER BLATT, AND MARGARET R. BALL (From the Surgical Research Laboratories
More informationTreatment of Diabetes Dr. Osama
diabetes practical 201 1 6 and type two Diabetes treatment diabetes treat
More informationIncrease Growth Hormone by 701% after only 90 minutes...naturally
BREAKTHROUGH UNIVERSITY STUDY REVEALS Increase Growth Hormone by 701% after only 90 minutes...naturally Summary key points 275% increase in insulin 701% increase in growth hormone 300% increase in IGF1
More informationEstimating the number of components with defects post-release that showed no defects in testing
SOFTWARE TESTING, VERIFICATION AND RELIABILITY Softw. Test. Verif. Reliab. 2002; 12:93 122 (DOI: 10.1002/stvr.235) Estimating the number of components with defects post-release that showed no defects in
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More informationProvider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes
Medi-Cal Managed Care L. A. Care Provider Bulletin December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease
More informationHypoglycemia. When recognized early, hypoglycemia can be treated successfully.
Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia
More informationGlucosuria: Diabetes Mellitus
172 PHYSIOLOGY CASES AND PROBLEMS Case 30 Glucosuria: Diabetes Mellitus David Mandel was diagnosed with type I (insulin-dependent) diabetes mellitus when he was 12 years old, right after he started middle
More informationA CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V.
A CLINICAL STUDY OF GESTATIONAL DIABETES MELLITUS IN A TEACHING HOSPITAL IN KERALA Baiju Sam Jacob 1, Girija Devi K 2, V. Baby Paul 3 HOW TO CITE THIS ARTICLE: Baiju Sam Jacob, Girija Devi K, V. Baby Paul.
More informationClient Information Sheet Copyright Bilton Veterinary Centre All rights Reserved. Diabetes Mellitus
What is Diabetes Mellitus? Diabetes Mellitus Diabetes mellitus (DM) is often called sugar diabetes in order to distinguish it from a condition called Diabetes insipidus, which is a totally separate condition.
More informationCase Study BMIs in the range of are considered overweight. Therefore, F.V. s usual BMI indicates that she was overweight.
Morgan McFarlane February 26 th, 2013 HHP 439 Professor White Case Study 7.10 1. What is your interpretation of F.V. s clinical data? F.V. s clinical data includes chronic abdominal pain, loose stools,
More informationA Virtual Glucose Homeostasis Model for Verification, Simulation and Clinical Trials
A Virtual Glucose Homeostasis Model for Verification, Simulation and Clinical Trials Neeraj Kumar Singh INPT-ENSEEIHT/IRIT University of Toulouse, France September 14, 2016 Neeraj Kumar Singh A Perspective
More informationSTUDIES IN BLOOD DIASTASE. FACTORS WHICH CAUSE. The effects of the following procedures on the blood diastase have
STUDIES IN BLOOD DIASTASE. FACTORS WHICH CAUSE VARIATIONS IN THE AMOUNT OF DIASTASE IN THE BLOOD. By CHARLES REID and B. NARAYANA. From the Department of Physiology, Prince of Wales Medical College, Patna.
More informationOGY. IV. THE METABOLISM OF IODINE IN
RADIOACTIVE IODINE AS AN INDICATOR IN THYROID PHYSIOL- OGY IV THE METABOLISM OF IODINE IN GRAVES' 1 By S HERTZ, A ROBERTS, AND W T SALTER (From the Thyroid Clinic of the Massachusetts General Hospital,
More informationNutrition. Chapter 45. Reada Almashagba
Nutrition Chapter 45 1 Nutrition: - Nutrient are organic substances found in food and are required for body function - No one food provide all essential nutrient Major function of nutrition: providing
More informationDiabetes, sugar. Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA (724)
Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA 16125 (724) 588-5260 Feline diabetes mellitus Diabetes, sugar AffectedAnimals: Most diabetic cats are older than 10 years of age when
More informationPosition Statement of ADA / EASD 2012
Management of Hyperglycemia in Type2 Diabetes: A Patient- Centered Approach Position Statement of ADA / EASD 2012 Cause of : Type 2 diabetes Cardiovascular disorders Blindness End-stage renal failure Amputations
More information